EP Patent

EP1082106B1 — Effervescent tablet for the sublingual, buccal and gingival administration of fentanyl

Assigned to Cima Labs Inc · Expires 2007-01-03 · 19y expired

What this patent protects

A pharmaceutical dosage form adapted to supply a medicament to the oral cavity for buccal, sublingual or gingival absorption of the medicament which contains an orally administerable medicament in combination with an effervescent for use in promoting absorption of the medicament …

USPTO Abstract

A pharmaceutical dosage form adapted to supply a medicament to the oral cavity for buccal, sublingual or gingival absorption of the medicament which contains an orally administerable medicament in combination with an effervescent for use in promoting absorption of the medicament in the oral cavity. The use of an additional pH adjusting substance in combination with the effervescent for promoting the absorption drugs is also disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
EP1082106B1
Jurisdiction
EP
Classification
—
Expires
2007-01-03
Drug substance claim
No
Drug product claim
No
Assignee
Cima Labs Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.